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        Changes in expression of two surface proteins, 
CD4 and CD8, which act as coreceptors in 
conjunction with the TCR, are commonly 
used markers for stages of T cell development. 
CD4  +  CD8  +   double positive (DP) thymocytes 
that express a mature TCR of appropriate speci-
fi  city undergo a positive selection process, up-
regulating survival factors and diff  erentiating 
into either CD4  +  CD8        or CD4       CD8  +   single 
positive (SP; CD4SP or CD8SP, respectively) 
thymocytes. However, positive selection can be 
further subdivided into stages based on corecep-
tor expression, including partial down-regula-
tion of both coreceptors to yield a CD4  lo  CD8  lo   
double dull (DD) phenotype, followed by re-
expression of CD4 to produce a CD4  +  CD8  lo   tran-
sitional phenotype (  1  –  3  ). Maintenance of CD4 
expression coupled with complete loss of CD8 or 
reexpression of CD8 and silencing of CD4 
in these transitional cells results in the mature 
CD4SP or CD8SP phenotype, respectively (  4  ). 
  DD thymocytes express cell surface and 
molecular markers that indicate that they are the 
product of positive selection (  1, 2  ). Indeed, pro-
duction of the DD phenotype has been used as 
an assay for identifi  cation of self-peptides that 
can mediate positive selection (  3  ). That there is 
a direct precursor  –  product relationship between 
DD and CD4  +  8  lo   cells is supported by the fact 
that development of DD thymocytes precedes 
that of CD4  +  8  lo   thymocytes during recovery 
from irradiation and, most directly, that DD 
thymocytes give rise to CD4  +  8  lo   cells in culture 
(  1, 5  ). Based solely on coreceptor expression, 
however, this is also a heterogeneous cell popu-
lation, likely containing both dying cells (  6  ) and 
transitional intermediates that are products rather 
than precursors of CD4  +  8  lo   cells ( 2, 7 ). CD4  +  8  lo   
cells themselves contain precursors for both CD4 
and CD8 T cells (  4, 8, 9  ), consistent with the 
induction of Zbtb7b (  10, 11  ) and Runx3 (  5  ), 
critical factors for CD4 and CD8 lineage devel-
opment, respectively, in this cell subpopulation. 
Moreover, it has been shown that class II MHC –
  specifi  c TCR-transgenic (Tg) DP thymocytes 
transition to CD4SP phenotype cells through DD 
and CD4  +  8  lo   stages when cultured with thymic 
epithelial cells expressing the cognate MHC 
specifi  city (  5  ). However, in a two-step reaggre-
gation system, these same DD thymocytes be-
come CD4  +  8  lo   and then CD8SP when cognate 
MHC interactions are removed (  5  ). Thus, a 
linear pathway of DD to CD4  +  8  lo   to SP appears 
to be the normal developmental progression 
during positive selection of both CD4 and CD8 
lineage T cells. Thymocytes bearing some speci-
fi  cities, however, may directly transit from a DD 
to CD8SP phenotype (  12  ). 
  Interestingly, the DD phenotype is a  refl  ection 
of reduced  Cd4   and  Cd8   gene expression (refer-
ence   13   and unpublished data). Evidence from 
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  CD8  +   cytotoxic and CD4  +   helper/inducer T cells develop from common thymocyte precursors 
that express both CD4 and CD8 molecules. Upon T cell receptor signaling, these cells initi-
ate a differentiation program that includes complex changes in CD4 and CD8 expression, 
allowing identifi  cation of transitional intermediates in this developmental pathway. Little is 
known about regulation of these early transitions or their specifi  c importance to CD4 and 
CD8 T cell development. Here, we show a severe block at the CD4  lo  CD8  lo   transitional stage 
of positive selection caused by loss of the nuclear HMG box protein TOX. As a result, CD4 
lineage T cells, including regulatory T and CD1d-dependent natural killer T cells, fail to 
develop. In contrast, functional CD8  +   T cells develop in TOX-defi  cient mice. Our data sug-
gest that TOX-dependent transition to the CD4  +  CD8  lo   stage is required for continued 
development of class II major histocompatibility complex  –  specifi  c T cells, regardless of 
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viable and fertile, and had no obvious abnormalities in appearance 
or behavior. We have not detected expression of TOX in 
developing B cells (unpublished data). Consistent with this, 
loss of TOX had no discernable eff  ect on stages of B cell 
development in the BM or appearance of mature B cells 
in the spleen (Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20071944/DC1). 
  TOX is expressed in early DN subsets and then tran-
siently during      selection, the process that initiates the DN to 
DP thymocyte progression (  22  ). There was no signifi  cant re-
duction in thymic cellularity in Tox      /      mice (  Fig. 2 A  ), nor 
loss of DN subsets as defi  ned by expression of CD44 and 
CD25, or CD117  +   early T lineage precursor (ETP) cells (for 
review see reference   24  ) (  Fig. 2, B and C  ).   Consistent with 
these results, the frequency and number of DP thymocytes in 
Tox      /      mice are comparable to that of wild-type animals 
(  Fig. 2, D  –  F  ). Thus, TOX is dispensable for T cell commit-
ment in the thymus as well as diff  erentiation and cell expan-
sion associated with      selection. 
  Thymocyte-intrinsic TOX is required for completion 
of positive selection of the CD4 lineage 
  Analysis of later stages of T cell development revealed that 
Tox      /      mice had a near complete loss of CD4  +  CD8  lo   tran-
sitional and CD4SP thymocytes (  Fig. 2, D  –  F  ). In contrast, 
marker Tg mice has suggested that the   Cd4   gene silencer may 
be transiently active in DD thymocytes (  13  ). In addition, there 
is data to suggest that regulation of the   Cd4   enhancer may 
diff  er between immature and mature T cells (  13  –  16  ). Similarly, 
changes in   Cd8   gene regulation occur as a result of positive 
selection (  17  –  19  ). Thus, the DD phenotype may refl  ect a 
  “  gear shift  ”   in coreceptor gene regulation. Whether the pheno-
type of these cells also has functional signifi  cance, however, 
remains unclear. Asymmetrical coreceptor expression at the 
later CD4  +  CD8  lo   stage, however, has been proposed to allow 
discrimination between class I and class II MHC  –  specifi  c TCR 
due to diff  erential dependence on CD8 or CD4 coreceptors 
for signaling (  9, 20  ). 
  Several nuclear factors have been identifi  ed that play key 
roles in coreceptor gene regulation and development to the 
CD4 or CD8 lineages (for review see reference   21  ). Never-
theless, much remains unknown about how the specifi  c phe-
notypic stages during positive selection are regulated, their 
linkage to TCR-mediated signaling, and their importance for 
T cell lineage diversifi  cation. 
  We have shown previously that the thymocyte selection  –
  associated HMG box protein (TOX) is transiently up-regulated 
by calcineurin-mediated TCR signaling in DP thymocytes as 
they develop into SP thymocytes (  22, 23  ). In this study, we 
describe TOX as a key regulator of the DD to CD4  +  8  lo   tran-
sition during positive selection. The absence of this nuclear 
protein prevents CD4 lineage T cell development, including 
CD1d-dependent natural killer T (NKT) and T regulatory 
(T reg) CD4 T cell sublineages, but has only modest eff  ects 
on CD8 T cell development. The failure of the majority of 
developing polyclonal CD4 lineage T cells to switch to the 
CD8 lineage in the absence of TOX further indicates the 
critical importance of the CD4  +  8  lo   stage to developmental 
progression of class II MHC  –  restricted T cells. 
    RESULTS   
  Germline deletion of   Tox   
  Using standard gene-targeting methodology, embryonic stem 
(ES) cells were produced in which   loxP   sites fl  anked a ge-
nomic region that included exon 1 and 1.7 kb upstream of 
the   Tox   gene. After transfection of Cre recombinase, ES cell 
clones were selected that deleted this genomic fragment as 
well as that encoding the co-integrated selectable markers 
(  Fig. 1 A  ).   Chimeric mice produced from these targeted ES 
cells were screened by Southern blotting (not depicted) and 
bred to produce heterozygous (Tox  +/     ) and homozygous 
(Tox      /     ) mutant mice, as screened by genomic PCR (  Fig. 1 B  ). 
Tox      /      mice did not express detectable   Tox   mRNA or TOX 
protein, the latter assessed using an antibody directed against 
a C-terminal peptide of TOX (  22, 23  ), when compared with 
Tox  +/+   or Tox  +/      mice (  Fig. 1, C and D  ). 
  Loss of TOX does not inhibit B cell development 
or thymic       selection 
    Tox   mRNA is detected in several tissues in addition to the 
thymus, including the brain (  22  ). However, Tox      /      mice were 
    Figure 1.         Generation of Tox       /      mice.   (A) Schematic of gene-target-
ing strategy to delete genomic region surrounding exon 1 of the   Tox   gene. 
The location of   loxP   sites (triangles), exon 1 (black box), transcription start 
sites (ATG; large arrows), and genomic PCR primers (small arrows) is 
shown. Location and direction of selectable marker gene cassettes encod-
ing thymidine kinase (HSVTk) and neomycin resistance (PGKneo) are also 
depicted. Restriction enzymes sites in   Tox   are indicated. H, HindIII; Nh, 
NheI; N, NcoI; B, BglII. (B) Genomic PCR for   Tox   in total thymocytes from 
Tox  +/+   (+/+),  Tox +/      (+/   ), and Tox     /     (  /   ) mice using combinations of 
primers shown in A demonstrates expected genomic structure of the 
targeted locus. (C and D) Loss of   Tox   mRNA demonstrated by RT-PCR (C) 
and TOX protein analyzed by immunoblotting (D) in total thymocytes 
from gene-targeted mice. Expression of the   Actb   gene and    -actin  pro-
tein was used for controls. In this and all subsequent fi  gures, protein 
masses are based on relative mobility in SDS-PAGE.     JEM VOL. 205, January 21, 2008 
ARTICLE
247
the DD thymocyte subpopulation was expanded threefold on 
average (  Fig. 2, D  –  F  ). Postpositive selection TCR  +   CD8SP 
thymocytes were present in Tox      /      mice at modestly reduced 
frequency on average that failed to reach statistical signifi  cance 
(P = 0.17) (  Fig. 2 E  ), although absolute cell numbers were 
signifi  cantly reduced (P = 0.005) (  Fig. 2 F  ). No T cell devel-
opmental defects were observed in Tox  +/      mice (  Fig. 2 D  ). 
Staining for CD4 and CD8     gave similar results (not depicted). 
  Analysis of TCR and CD5 expression is useful to delineate 
stages of positive selection ( 25  ). In wild-type mice, TCR  lo  CD5  lo   
cells consisted of preselection DP thymocytes, TCR  lo  CD5  int   cells 
were DP cells initiating positive selection, TCR  int  CD5  hi   cells 
were DD and CD4  +  8  lo   thymocytes in the process of positive 
selection, and TCR  hi  CD5  hi   cells were primarily postselection 
CD4SP and CD8SP thymocytes (stages 1  –  4, respectively; 
  Fig. 2 G  ). In Tox      /      mice, preselection and early selection 
DP stage 1 and 2 cells, respectively, were present normally, 
stage 3 cells undergoing positive selection were increased in 
frequency but lacked CD4  +  8  lo   cells, and stage 4 CD4SP thy-
mocytes were absent (  Fig. 2 G  ). Some stage 4 cells were pres-
ent in Tox      /      mice, although with somewhat reduced TCR 
expression, and these were primarily CD8SP thymocytes 
(  Fig. 2 G  ). These data indicate that Tox      /      thymocytes initi-
ated positive selection (stages 1  –  3) but failed to complete de-
velopment to subsequent CD4  +  8  lo   and CD4SP stages. 
  These results were confi  rmed with an additional marker of 
positive selection, CD69 (  26  ). In this instance, stages 1  –  4 were 
defi  ned as TCR -/lo  CD69       , TCR int  CD69  lo/hi  , TCR hi  CD69  hi  , 
and TCR  hi  CD69  lo/      cells, respectively, with a progression of 
coreceptor changes similar to the subpopulations defi  ned 
above by expression of TCR and CD5 (Fig. S2, available at 
http://www.jem.org/cgi/content/full/jem.20071944/DC1). 
In Tox      /      mice, preselection DP stage 1 cells were present 
normally, stage 2 cells undergoing positive selection were in-
creased in frequency but lacked CD4  +  8  lo   cells, and stage 3 
and 4 CD4SP thymocytes were absent (Fig. S2). The stage 4 
cells that were present in Tox      /      mice were primarily CD8SP 
thymocytes (Fig. S2). 
  The normal initiation of positive selection in Tox      /      mice 
(  Fig. 2 G   and Fig. S2) suggested that there was no defect in 
TCR signaling in the mutant thymocytes. To address this 
more directly, we analyzed calcium fl  ux and phosphorylation 
of extracellular signal  –  regulated kinases 1 and 2 (ERK1 and 2) 
in response to CD3 cross-linking, aspects of two signaling 
pathways known to be required for positive selection (  21  ). 
Although TOX is poorly expressed by DP thymocytes (  22  ), 
perturbations in      selection can impact the signaling properties 
of later-stage DP thymocytes ( 27  ). Because TOX is also up-regu-
lated during      selection (  22  ), we sought to determine if TOX 
defi  ciency altered TCR signaling in DP cells, as well as in DD 
thymocytes that normally up-regulate TOX. In these assays, 
wild-type and Tox      /      DP and DD thymocytes were indistin-
guishable (  Fig. 3, A and B  ).   To assess the outcome of TCR 
engagement on these cells, we analyzed the response of DP 
thymocytes to an anti  –  TCR-    /CD2 mAb combination that 
has been shown to deliver a diff  erentiation signal leading to 
    Figure 2.         TOX is required for CD4SP thymocyte development but 
not initiation of positive selection.   (A) No statistically signifi  cant 
difference (P = 0.28) in total thymic cellularity of individual +/+ and 
   /    mice was observed. Mice ranging in age from 2.5 to 9 wk were ana-
lyzed as age-matched control and experimental pairs. Population means 
are shown as horizontal bars. (B) Maintenance of CD44- and CD25-
defi  ned DN subsets in lineage        (CD4     ,  CD8       ,  B220     ,  DX-5     ,  and 
     TCR      ) thymocytes from Tox     /     mice. Numbers indicate frequency of 
DN1 (CD44  +  CD25), DN2 (CD44  + CD25 +  ), DN3 (CD44      CD25 +  ), and DN4 
(CD44  + CD25      ) subsets. (C) Maintenance of CD117- and CD25-defi  ned 
DN subsets and ETP in lineage        (CD8       ,  CD8       ,  CD3       ,  TCR-       , 
CD11b      ,  CD11c     ,  TER119     ,  CD19     ,  B220     ,  NK1.1      , and      TCR     )  thy-
mocytes from Tox     /     mice. ETP (CD117  + CD25      ), DN2 (CD117  + CD25 + ), 
DN3 (CD117      CD25 +  ), and DN4 (CD117  + CD25      ) subsets are depicted. 
(D) Representative CD4/CD8 staining patterns of thymocytes derived from 
+/+, +/    , and    /    mice are shown. Numbers indicate frequency of 
indicated thymocyte subsets, expressed as a percentage in this fi  gure 
and all subsequent fi  gures unless otherwise indicated. (E) Compilation 
of the frequency of CD4- and CD8-defi  ned thymocyte subsets in +/+ 
and    /    mice. CD8SP thymocytes were also gated on TCR  +   cells  to 
eliminate immature CD8SP thymocytes from the analysis. Statistically 
signifi  cant differences between the mean frequency of DD (P = 4.10     11 ) 
and 4SP (P = 1.10     12  ) +/+ and    /    thymocytes are indicated (**). 
(F) Absolute numbers of thymocyte subsets in +/+ (gray bars) and    /   
(black bars) mice. Error bars refer to standard deviations (  n   = 16). Sta-
tistically signifi  cant differences between the mean absolute number of 
DD (P = 5.7   ×   10     6  ), 4SP (P = 1.9   ×   10     10  ), and 8SP (P = 0.0047) +/+ 
and    /    thymocytes are indicated (**) (G) Tox     /     thymocytes  initiate 
positive selection based on marker up-regulation. Two-parameter anal-
ysis for expression of TCR-     and CD5 allows identifi  cation of develop-
mental stages (labeled 1  –  4) that were then assessed for expression 
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associated with      selection, and did not prevent CD8SP thymo-
cyte production (  Fig. 4 A   and not depicted). 
  Histological analysis of the thymus of a mixed BM chi-
mera revealed normal thymic architecture and distribution of 
Tox  +/+   (CD45.1) and Tox      /      (CD45.2) thymocytes through-
out the cortex and medulla (  Fig. 4 B  ). Because Tox      /      cells 
fail to develop into CD4 T cells (  Fig. 4 A  ), the CD45.2  +   medul-
lary thymocytes presumably correspond to CD8SP thymocytes. 
These results confi  rm that developmental defects observed in 
Tox      /      mice are cell intrinsic and, moreover, that CD4SP 
thymocytes do not develop in the absence of TOX even in 
the context of a normal thymic microenvironment. 
  Molecular signature of Tox       /       DD thymocytes places them 
after positive selection and pre-lineage commitment 
  Dying thymocytes can take on a DD-like phenotype (  6  ). 
However, there was no increase (and some decrease) in the 
frequency of annexin V  +   cells, an early marker of apoptosis, 
among freshly isolated Tox      /      DP or DD thymocytes com-
pared with their wild-type counterparts (  Fig. 5 A  ).   Mutant 
and wild-type thymocytes also showed similar extents of 
spontaneous cell death and anti-CD3    /CD28 mAb  –  induced 
cell death (  Fig. 5 B  ). Expression of all three isoforms of the pro-
apoptotic factor Bim, which play a role in negative selection 
(  29  ), were detected in wild-type DD thymocytes. A similar 
pattern of isoform expression has been previously reported in 
progression to a DD phenotype (  28  ). DP thymocytes from 
both wild-type and Tox      /      mice developed into DD thymo-
cytes in culture in response to this stimulus, further demon-
strating that TCR signaling necessary for transition to a DD 
phenotype is intact in the absence of TOX (  Fig. 3 C  ). 
  To ensure that the defects observed in T cell develop-
ment were intrinsic to thymocytes, we reconstituted lethally 
irradiated wild-type mice with a 1:1 mix of Tox      /      (CD45.2  +  ) 
and control Tox  +/+   (CD45.1  +  ) BM cells. In these mixed chi-
meric mice, developing Tox      /      cells recapitulated the phe-
notype of intact Tox      /      mice, including loss of CD4 T cell 
development, increase in DD thymocytes, and reduction of 
TCR  hi  CD5  hi   thymocytes (  Fig. 4 A  ).   Despite these develop-
mental defects, cells that had initiated positive selection (cor-
responding to stages 2 and 3 in   Fig. 2 G  ) were not diminished 
(  Fig. 4 A  ). In contrast, Tox  +/+   cells in the same animal devel-
oped normally (  Fig. 4 A  ). Even under these competitive condi-
tions, loss of TOX had no discernible eff  ect on cell expansion 
    Figure 3.         TCR signaling is intact in the absence of TOX.   (A)  Analysis 
of anti-CD3     mAb induced calcium fl  ux in wild-type (blue line) or Tox     /    
(red line) gated populations of DP or DD thymocytes, as indicated. Control 
(black line) refers to Tox     /     thymocytes that were treated with anti-CD3    
mAb but did not receive the cross-linking secondary antibody. (B) Induc-
tion of phospho-ERK1/2 in DP and DD thymocytes upon TCR cross-linking 
as in A. To validate the specifi  city of staining, PMA stimulation of DP thy-
mocytes with or without the MAPK or ERK kinase (MEK) inhibitor U0126 
is also shown. (C) Purifi  ed DP thymocytes were analyzed directly (t = 0) or 
induced to differentiate by overnight culture without (medium) or with 
coimmobilized anti-CD2 and anti  –  TCR-     antibodies  as  indicated.   
    Figure 4.         The Tox       /      phenotype is T cell intrinsic.   (A)  Thymocytes 
from irradiated wild-type (B6, CD90.1  +  ) mice reconstituted with a 1:1 
mixture of CD90.2  + CD45.2 +   mutant  (  /   ) and CD90.2  + CD45.1 +   wild-type 
(B6) BM-derived cells were analyzed as shown. (B) Tox     /     thymocytes 
appear in the thymic cortex and medulla in mixed chimeric mice. Medul-
lary regions are defi  ned by staining of medullary epithelium with   Ulex 
europaeus   agglutinin I (UEA; red), wild-type (B6) cells are detected with 
anti-CD45.1 mAb (green), and mutant cells are detected with anti-CD45.2 
mAb (blue). Bar, 100    m.   JEM VOL. 205, January 21, 2008 
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  selection DD cells and/or the lack of CD4 lineage thymocytes 
that would normally be subjected to negative selection. 
  Because Tox      /      thymocytes initiated positive selection 
but specifi  cally failed to progress in their diff  erentiation pro-
gram to the CD4 lineage, we investigated whether this failure 
was associated with an inability to up-regulate T cell lineage  –
  specifi  c factors. The Zbtb7b zinc fi  nger transcription factor is 
specifi  cally expressed in developing thymocytes of the CD4 
lineage, and both gain-of-function and loss-of-function ap-
proaches have demonstrated that this nuclear protein is both 
necessary and suffi   cient for commitment to the CD4 T cell 
lineage (  10, 11  ). DP thymocytes from either mutant or wild-
type mice did not express   Zbtb7b   mRNA (  Fig. 5 D  ).   Zbtb7b   
mRNA, however, was present in developing AND TCR-Tg 
thymocytes (~60% CD4SP) and at ~25-fold lower amounts 
in wild-type DD thymocytes (  Fig. 5 D  ). In contrast, DD 
thymo  cytes isolated from Tox      /      mice did not express de-
tectable amounts of   Zbtb7b   mRNA, consistent with the in-
ability of these postselection thymocytes to develop into CD4 
T cells (  Fig. 5 D  ). 
  Expression of   Gata3  , up-regulated by TCR activation 
during positive selection and required for CD4 lineage develop-
ment or survival (  31, 32  ), was up-regulated in both wild-type 
and mutant DD thymocytes when compared with their re-
spective DP thymocyte populations (  Fig. 5 D  ). Expression of 
  Rag1   is extinguished early during positive selection, prevent-
ing additional TCR gene rearrangements once the selection 
process has initiated (  33  ). Compared with DP thymocytes, 
DD thymocytes from both wild-type and Tox      /      mice down-
regulated   Rag1   (  Fig. 5 D  ). These data indicate that Tox      /      
DD thymocytes are postpositive selection but blocked at a 
stage before CD4 lineage commitment. 
  Runx3 protein is expressed in the CD8 but not CD4 T 
cell lineage in the thymus (  5  ). Moreover, development of the 
CD8SP phenotype is dependent on this nuclear factor, both 
to initiate   Cd4   gene silencing and to activate a   Cd8   gene en-
hancer (  5, 34, 35  ). As expected, Runx3 was undetectable in 
wild-type DP thymocytes but was highly expressed by CD8SP 
thymocytes (  Fig. 5 E  ). Similarly, Runx3 protein was expressed 
by Tox      /      CD8SP but not DP thymocytes, suggesting that 
the CD8SP phenotype in Tox      /      mice was a refl  ection of CD4 
silencing (  Fig. 5 E  ). Both wild-type and Tox      /      DD cell 
populations expressed low levels of Runx3 (  Fig. 5 E  ). 
  Functional CD8 T cells develop in the absence of TOX 
and CD4  +  8  lo   transitional thymocytes 
  The severe inhibition of thymic CD4SP development in 
Tox      /      mice resulted in signifi  cant T lymphopenia in the 
spleen, which could be attributed specifi  cally to loss of CD4 
T cells ( Fig. 6, A –  C  ).   Compared with wild-type mice, Tox      /      
mice had, on average, 24- and 16-fold reductions in the fre-
quency and absolute number of splenic CD4 T cells, respec-
tively. In addition, the CD4 T cells present in Tox      /      mice 
were almost all CD44  hi   (  Fig. 6 A  ). Because T cells under-
going homeostatic expansion in lymphopenic animals also up-
regulate CD44 (  36  ), it is possible that rare CD4 T cells that 
thymocytes undergoing TCR-mediated apoptosis (  30  ), suggest-
ing that the DD population may include some thymocytes 
undergoing negative selection (  Fig. 5 C  ). However, expression 
of Bim was reduced in mutant DD thymocytes (  Fig. 5 C  ), 
arguing against the possibility that the Tox      /      DD thymo-
cytes result from enhanced negative selection. The reduction 
in apoptotic cells and expression of Bim in the Tox      /      DD 
cell population could be due to dilution with postpositive 
    Figure 5.         Tox       /      DD thymocytes are after positive selection but do 
not express the CD4 lineage commitment factor.   (A) Total viable thy-
mocytes, as determined by PI exclusion (PI       ), were analyzed for binding 
of annexin V to gated populations of DP and DD thymocytes. (B) Purifi  ed DP 
thymocytes were treated with various concentrations of plate-bound 
anti-CD3     mAb in the presence of anti-CD28 mAb. Cell viability was de-
termined by PI and annexin V staining after overnight culture. Plotted 
frequencies represent mean   ±   SD of duplicate cultures. (C) The proapop-
totic factor Bim is poorly expressed by the Tox     /     DD thymocyte popula-
tion compared with wild-type. Total cell lysates from purifi  ed DD 
thymocytes were analyzed for Bim by Western blotting. BimEL is the 
prominent isoform present, although BimL and BimS were also detectable 
with longer exposure. Expression of     -actin was used as a loading con-
trol. (D) Quantitative real-time RT-PCR for   Zbtb7b ,   Gata3  , and   Rag1  
mRNA in purifi  ed populations of DP or DD thymocytes. Results are com-
pared with mRNA derived from AND TCR-Tg total thymocytes, which was 
arbitrarily set to a value of 1.0. Where bars are not graphically visible, 
values or not detectable (ND) (C  t     >   33 cycles) is indicated. (E) Runx3 pro-
tein is up-regulated in Tox     /     CD8SP thymocytes. Total cell lysates from 
sorted thymocyte populations were analyzed for expression of Runx1 and 
Runx3 by immunoblotting using a pan anti-Runx antibody. Expression of 
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develop in the Tox      /      thymus undergo considerable expansion 
in the spleen. In contrast, splenic CD8 T cell numbers were 
not reduced in Tox      /      compared with wild-type animals 
(  Fig. 6 C  ). However, the proportion of CD8 T cells that were 
CD44  hi   also increased somewhat in Tox      /      mice (  Fig. 6 A  ). 
Nevertheless, isolated Tox      /      splenic CD8 T cells showed 
normal proliferative responses to anti-CD3/CD28 mAb stim-
ulation in the absence or presence of IL-2 (  Fig. 6 D  ). 
  To determine whether the phenotypically defi  ned T cells 
present in Tox      /      mice were true CD8 lineage T cells, we 
analyzed up-regulation of CD40L and IFN-    . CD40L was 
induced on activated CD4 but not CD8 T cells derived from 
wild-type or mutant mice (  Fig. 6 E  ). Conversely, IFN-     pro-
duction was more pronounced from activated wild-type or 
mutant CD8 T cells than wild-type CD4 T cells. In addition, 
Tox      /      CD8 T cells developed into cytolytic eff  ector cells 
upon stimulation with allogeneic spleen cells (  Fig. 6 F  ), al-
though some reduction in cytolytic activity was noted when 
compared with wild-type eff  ector cells (  Fig. 6 G  ). By these 
criteria, CD8 T cells that develop in Tox      /      mice show an 
appropriate match of coreceptor expression with associated 
T lineage eff  ector functions. 
  Lineage commitment in the absence of TOX 
  The loss of CD4SP thymocytes and lack of a compensatory 
increase in CD8SP thymocytes in Tox      /      mice suggested that 
class II MHC  –  restricted T cells were unlikely to be misdirected 
to the CD8 lineage in these animals. To address this directly, 
we generated       2  -microglobulin (      2  M)-defi  cient  (      2  M      /     ) 
Tox      /      mice. Up-regulation of TCR-     from the DD to the 
CD8SP stages of development was evident in all strains, in-
dicative of positive selection (  Fig. 7 A  ).   However, numbers 
of TCR  +   CD8SP cells were greatly reduced in       2  M      /      
Tox      /      mice when compared with Tox      /      mice (  Figs. 2 F 
and 7, A and B  ). Similar results were obtained in the spleen, 
where CD8 T cells in       2  M      /      Tox      /      mice were reduced 
approximately fi  vefold when compared with Tox      /      mice 
(Fig. S3, available at http://www.jem.org/cgi/content/full/
jem.20071944/DC1). These results demonstrate that develop-
ment of the majority of CD8 lineage T cells in Tox      /      mice 
was class I MHC dependent. 
  Nevertheless, numbers of TCR  +   CD8SP cells were greater 
in       2  M      /      Tox      /      mice than in       2  M      /      mice (  Fig. 7, A and B  ). 
The splenic CD8 T cell population in       2  M      /      Tox      /      mice 
was also more pronounced than that seen in the       2  M      /      strain 
(Fig. S3). In addition, class I MHC  –  defi  cient mice (      2  M      /      
or transporter associated with antigen processing [TAP]-1      /     ) 
reconstituted with Tox      /      BM revealed an increase in num-
bers of TCR  +   CD8SP cells compared with those reconstituted 
with wild-type BM, suggesting a   thymocyte-intrinsic eff  ect 
(  Fig. 7 B  ). These data indicate class I MHC  –  independent 
development of a minor population of CD8 T cells in the 
absence of TOX. 
  To determine whether TOX defi  ciency aff  ects the devel-
opment of CD8 T cells of known specifi  city, we analyzed 
class I MHC  –  specifi  c OT-I TCR-Tg mice. Development of 
    Figure 6.         CD4 T lymphopenia but functional CD8 T cells in 
Tox       /      mice.   (A) Profound loss of CD4 T cells and increase in fre-
quency of CD44  hi   T cells in the spleens of Tox     /     mice as shown by 
four-color flow cytometry analysis. (B) Frequencies of TCR-    +   spleen 
cells are plotted for individual mice. Population means are shown as 
bars. A statistically significant reduction in the frequency of TCR-    +  
spleen cells (P = 5.3   ×   10     8  ) in    /    compared with +/+ mice is indi-
cated (**). (C) Absolute numbers of total splenocytes, splenic T cells, 
and CD4 and CD8 T cell subsets in +/+ (gray bars) and    /    (black 
bars) mice. Error bars refer to standard deviations (  n   = 11). Statisti-
cally significant reductions in the number of TCR-    +   spleen cells (P = 
0.026) and CD4 T cells (P = 3.10     4  ) in    /    compared with +/+ mice 
are indicated (**). (D) Tox     /     CD8 T cells are responsive to TCR activa-
tion. Proliferative response (mean [  3 H]-thymidine  incorporation   ±   SD 
of triplicate cultures) of wild-type (gray bars) or Tox     /     (black  bars) 
splenic CD8 T cells to anti-CD3     and anti-CD28 mAb stimulation in 
the presence or absence of IL-2. (E) Mutant CD8 splenic T cells belong 
to the CD8 lineage. Gated populations of +/+ or    /    CD4 and CD8 
splenic T cells were analyzed for induction of CD40L and IFN-     pro-
duction after culture in the absence (shaded) or presence (black line) 
of PMA and ionomycin. (F and G) Tox     /     CD8 T cells exhibit cytotoxic 
effector function. In vitro B10.BR (H-2  k  )-stimulated CD8 T cells from 
C57BL/6 or H-2  b   TOX    /     mice were tested for cytotoxicity against a 
mix of allogeneic CFSE  hi   B10.BR (BR) and syngeneic CFSE  lo   C57BL/6 
(B6) target cells. Cytolytic activity was determined by specific loss of 
CFSE  hi  -viable cells by flow cytometry using an E/T ratio of 10 in F, or 
as indicated in G, and calculated as in Materials and methods.     JEM VOL. 205, January 21, 2008 
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by CD5 up-regulation (  Fig. 7 E  ). As a result of this develop-
mental block, the spleens of DO11 TCR-Tg Tox      /      mice 
exhibited severe T lymphopenia (  Fig. 7 F  ). The minor popu-
lation of splenic T cells present in these animals was predomi-
nantly CD8  +   (  Fig. 7 F  ). 
  Expression of transgene-encoded TOX but not a DNA-binding 
domain mutant rescues CD4 T cell development in Tox       /       mice 
  To defi  nitively demonstrate that loss of TOX is responsible for 
the observed block in T cell development in mutant mice, we 
bred Tox      /      mice to TOX-Tg mice (  22  ). As expected, expres-
sion of the TOX transgene reconstituted CD4 T cell develop-
ment in Tox      /      mice, including the production of TCR  int/hi   
CD4  +  8  lo   transitional and CD4SP thymocytes (  Fig. 8 A  ).   This 
was accompanied by a reduction in the DD population in 
Tox      /      TOX-Tg mice, relative to Tox      /      mice (  Fig. 8 A  ). 
In addition, the TCR  hi  CD5  hi   thymocyte subpopulation that 
was absent in Tox      /      mice was restored by expression of trans-
gene-encoded TOX (stage 4 in   Figs. 2 D   and   8 B  ). Previously, 
we reported that CD8SP thymocyte development was en-
hanced in TOX-Tg mice in the absence of positive selection 
(  Fig. 8 A  ) (  23  ). This increase in CD8SP thymocytes was also 
evident in Tox      /      TOX-Tg mice (  Fig. 8 A  ). In addition, 
Tox      /      TOX-Tg mice had a population of TCR  int/hi  CD5  lo/      
(stage 5) CD8SP thymocytes (  Fig. 8 B  ) not present in wild-type, 
Tox  +/     , or Tox      /      mice, but evident in Tox  +/      TOX-Tg and 
Tox      /      TOX-Tg mice (  Figs. 2 D   and   8 B  ). A similar population 
of cells was observed previously in TOX-Tg mice on a       2  M      /      
background, suggesting that these cells are formed by ectopic 
expression of TOX in the absence of positive selection (  22  ). We 
also produced Tg mice that express a mutant of TOX that lacks 
the HMG box domain (  	  HMG-Tg) but maintained nuclear lo-
calization signals and was expressed at the level of protein (  21  ). 
Expression of TOX  	  HMG was unable to restore CD4 T cell 
development in Tox      /      mice (  Fig. 8, C and D  ). Thus, the 
DNA-binding domain of TOX is critical for its function. 
  Other TOX-dependent T cell lineages 
  CD1d-dependent NKT, many T reg cells, and         T require 
the thymic environment for development. Mature T cells of 
these cell lineages diff  er in coreceptor expression; mature         T 
cells are DN or CD8          +   (  37  ), NKT cells are CD4  +   or DN 
(  38  ), and T reg cells are mostly CD4  +   (  39  ). In addition,         T cells 
develop from DN thymocytes (  40  ), whereas NKT and T reg 
cells develop from DP thymocytes as a result of a positive 
selection process (  38, 41  ). Thus, we asked how loss of TOX 
would aff  ect development of these distinct T cell lineages. 
  NKT cell precursors, defi  ned as CD3  int       -galactosylce-
ramide (    GalCer)-CD1d tetramer  +   thymocytes (  42  ), were 
severely reduced in the thymuses (  Fig. 9, A and B  ) and spleens 
(  Fig. 10 A  ) of Tox      /      mice.   This was not caused by the 
absence of the selecting MHC molecule because loss of TOX 
had no eff  ect on expression of CD1d by DP thymocytes (  Fig. 
9 C  ). In wild-type mice, the majority of T reg cell precursor 
thymocytes, defi  ned by expression of the Foxp3 transcription 
factor (  41, 43  ), expressed CD4 (  Fig. 9 D  ). In Tox      /      mice, 
CD5  hi  V    2  hi   CD8SP thymocytes was unaff  ected by the absence 
of TOX in OT-I TCR-Tg mice, despite the loss of CD4  +  8  lo   
transitional cells in the mutant animals (  Fig. 7 C  ). CD8          +   T 
cells  that expressed high levels of transgene-encoded TCR 
(V    5 and V    2) were also predominant in the spleens of both 
wild-type and Tox      /      OT-I mice (  Fig. 7, C and D  ). In con-
trast, SP thymocytes bearing the class II MHC  –  restricted 
DO11 TCR failed to develop in the absence of TOX, despite 
the fact that the majority of thymocytes in DO11 TCR-Tg 
Tox      /      mice had received positive selection signals as assessed 
    Figure 7.         Preferential development of class I but not class II 
MHC  –  specifi  c T cells in Tox       /      mice.   (A) Reduced development of TCR-    +   
CD8SP in the absence of class I MHC. TCR-     expression on CD8SP (black 
line) is compared with DD thymocytes (shaded). Gate frequencies refer to 
the CD8SP subsets. The absolute number of TCR-    +   CD8SP cells in each 
animal is indicated above the TCR-     profi  les. (B) Absolute numbers of 
TCR  +   CD8SP thymocytes in     2 M    /   ,     2 M    /     Tox    /     mice, and lethally 
irradiated     2 M    /     or  TAP-1    /     (TAP    /    ) mice reconstituted with either 
wild-type (WT) or Tox     /     BM. (C) CD8SP thymocytes develop in OT-I TCR-
Tg Tox     /     mice. Expression of CD4 and CD8 on total thymocytes or CD5 
and V    2 on gated CD8SP thymocytes is shown. (D) CD8 splenic T cells 
develop in OT-I TCR-Tg Tox     /     mice. Expression of CD8   ,  V   5, and V   2 
on a gated subpopulation of CD8    +   splenic T cells from +/+ (shaded) and 
   /    (black line) mice. (E) Total thymocytes were analyzed for CD4, CD8, 
CD5, and DO11 TCR expression. (F) Splenocytes were stained for CD4, CD8, 
and TCR-    . Shown is the expression of CD4 and CD8 on TCR-    +   cells.   252 TOX IS REQUIRED FOR CD4 T CELL DEVELOPMENT | Aliahmad and Kaye
gross abnormalities outside the immune system were observed 
in Tox      /      mice. The ability of thymocytes to undergo cell 
diff  erentiation and expansion as a result of      selection was also 
largely unimpaired in Tox      /      mice. This was surprising 
because TOX is transiently up-regulated during      selection, 
and expression of transgene-encoded TOX is suffi   cient to 
induce   Cd8   gene demethylation and DN to DP diff  erentiation, 
although not cell expansion, of RAG-defi  cient thymocytes (  23  ). 
Whether the failure to detect a role for TOX during      selection 
is due to compensation from other TOX family members (  44  ), 
however, remains to be determined. 
  The most striking phenotype of Tox      /      mice was initia-
tion but not completion of positive selection of CD4 lineage 
T cells, leading to severe CD4 T lymphopenia. This was caused 
by a block at the DD to CD4  +  8  lo   transition in the thymus, 
consistent with the high level of TOX in these cell subpopu-
lations in wild-type mice (  22  ). 
few Foxp3  +   cells were detected in the thymus (  Fig. 9, D and E  ), 
whereas a low frequency of Foxp3  +   T cells was present in the 
spleen (  Fig. 10 B  ).   Although wild-type T reg cells are almost 
entirely CD4  +   and the majority express CD25, Foxp3  +   sple-
nocytes from Tox      /      mice contained a sizeable proportion 
of DN cells that were CD25        (  Fig. 10 B  ). These results con-
trasted with         T cell precursors, which were not reduced in 
the thymus of Tox      /      mice when compared with wild-type 
animals (  Fig. 9, F and G  ). 
    DISCUSSION   
  Our results have demonstrated that TOX plays a critical role 
in the development of T but not B lymphocytes, consistent 
with the expression pattern of this nuclear protein (  22  ). Ex-
pression of TOX, however, is not T cell specifi  c. Despite this, no 
    Figure 8.         Expression of transgene-encoded TOX rescues CD4 T cell 
development in Tox       /      mice.   (A) Frequency of cell populations in Tox  +/     
(+/   ),  Tox    /     (  /  ),  Tox +/      TOX-Tg  (+/    TOX-Tg), and Tox     /     TOX-Tg 
(   /    TOX-Tg) mice in total thymocytes (top panels) or in TCR  int/hi -gated 
thymocytes (bottom panels). Mean cell numbers of mature TCR  +   CD4SP  and 
CD8SP thymocytes are shown, and error bars indicate standard deviation 
(  n   = 3). (B) Five subpopulations (labeled 1  –  5) of Tox  +/      (+/  ),  Tox    /     (  /  ), 
Tox  +/      TOX-Tg (+/     TOX-Tg), and Tox     /     TOX-Tg  (  /    TOX-Tg)  thymocytes 
based on expression of TCR and CD5 were analyzed. Expression of CD4 and 
CD8 on Tox     /     TOX-Tg  (  /    TOX-Tg) thymocytes gated on CD5 and TCR is 
shown. (C and D) The frequency of thymocyte populations in Tox  +/      (+/  ) 
  	  HMG-Tg and Tox     /     (  /  )   	  HMG-Tg mice, stained as indicated.     
    Figure 9.         Development of                 T but not NKT or T reg cell precursor 
thymocytes in Tox       /       mice.   (A) Inhibition of development of CD1d-
dependent NKT cells in the thymus of Tox     /     mice as indicated by loss of 
CD3  int     GalCer-CD1d  tetramer +   thymocytes. (B) Compilation of data for 
individual animals generated as in A. (C) Expression of CD1d on +/+ (shaded 
histogram) and    /    (thick black line) DP thymocytes. Control isotype 
staining (thin black line) is shown on    /    DP thymocytes. (D) Inhibition of 
development of T reg cells in the thymus of Tox     /     mice as indicated by the 
loss of Foxp3  +   thymocytes, the vast majority of which are CD4  +   in  wild-type 
mice. (E) Compilation of data for individual animals generated as in D. 
(F) Frequency (percentage) of      TCR +   cells among otherwise lin        thymo-
cytes in Tox     /     mice. (G) Compilation of analysis of six    /    and +/+ animal 
pairs expressed as the (   /   )/(+/+) ratio of the frequency of      TCR +   thymo-
cytes in each experiment. The frequency of      TCR +   thymocytes was deter-
mined in total viable thymocytes, DN thymocytes, or lin        DN thymocytes in 
individual experiments. The mean ratio value is shown as a horizontal bar.    JEM VOL. 205, January 21, 2008 
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However, even in DD thymocytes, low-level Zbtb7b expression 
was not detected in Tox      /      mice. Therefore, TOX could play 
a more direct role in Zbtb7b up-regulation. Because TOX is 
expressed during both CD4 and CD8 lineage development, 
an additional CD4 lineage  –  specifi  c factor(s) would be required 
to induce Zbtb7b in CD4-destined cells. 
  Interestingly, the integration of lineage commitment with 
positive selection was largely intact in mice lacking TOX. 
Thus, the majority of CD8          +   T cells that developed in 
Tox      /      mice were class I MHC specifi  c, as assessed by loss of 
most CD8 T cells in       2  M      /      Tox      /      mice. The minor pop-
ulation of CD8 T cells that did develop in these animals, 
however, may be comprised of a subset of cells with class II 
MHC  –  specifi  c TCR. Similarly, OT-I (class I MHC  –  specifi  c) 
but not DO11 (class II MHC  –  specifi  c) TCR transgenes pro-
moted the development of CD8 T cells in Tox      /      mice. 
  The absence of CD4  +  8  lo   thymocytes in Tox      /      mice 
demonstrates that this transitional population is not an abso-
lute requirement for CD8 lineage development. Indeed, in 
mice that expressed a limited TCR repertoire, cells with 
certain TCR specifi  cities were found to be enriched in the 
CD8SP but not CD4  +  8  lo   thymocyte populations (  12  ). Thus, 
cells bearing some class I MHC specifi  cities may skip the 
CD4  +  8  lo   stage altogether. This could account for the ability 
of CD8 T cells to develop in Tox      /      mice. The frequency of 
CD4  +  8  lo   cells varies appreciably between diff  erent class I 
MHC  –  specifi  c TCR-Tg mice (  47  ). However, even in OT-I 
TCR-Tg mice that normally contain a pronounced CD4  +  8  lo   
cell population, CD8 T cell development was maintained in 
the absence of TOX and these transitional cells. Thus, under 
normal circumstances in the presence of TOX, many or most 
CD8 T cells may develop from the CD4  +  8  lo   stage via a   “  co-
receptor reversal  ”   pathway as has been proposed (  8  ). 
  The question arises then of why class II MHC  –  specifi  c T 
cells are not shunted into the CD8 lineage as they pass through 
the DD stage, as might be expected due to CD4 coreceptor 
down-regulation (  48  ). We suggest that CD4-dependent se-
lection of class II MHC specifi  cities during the initiation of 
positive selection may involve lineage specifi  cation, although 
not fi  xed commitment. This may help maintain appropriate 
lineage commitment as cells undergo complex changes in co-
receptor expression. In support of this, repositioning of the 
  Cd8   gene locus to heterochromatin in class II MHC  –  specifi  c 
AND TCR-Tg cells is detectable as early as the DD stage (  7  ). 
Despite this apparent specifi  cation, AND TCR-Tg cells can 
undergo CD8 lineage commitment when CD4  +  8  lo   cells form 
in the absence of Zbtb7b (  10, 11  ), indicating the maintenance 
of plasticity as late as the CD4  +  8  lo   stage. 
  This model predicts that normal lineage commitment 
would break down in the case of CD4-independent class II 
MHC specifi  cities. Indeed, cells expressing class II MHC  –
  specifi  c TCR develop into CD8 or DN T cells in CD4-defi  -
cient mice (  49, 50  ). Similarly, class II MHC  –  specifi  c AND or 
DO11 TCR-Tg thymocytes have been reported to adopt a 
CD8 lineage fate in mice that lack CD4, although this re-
quires expression of MHC molecules of suffi   cient affi   nity for 
  The TOX dependence of the DD to CD4  +  8  lo   transition 
provides the fi  rst molecular evidence that this subset repre-
sents a distinct stage of positive selection. In this regard, the 
phenotype of Tox      /      mice diff  ers from that of mice defi  cient 
in GATA-3 or functional Zbtb7b in several critical charac-
teristics. GATA-3 is also required for development or sur-
vival of conventional CD4 but not CD8 T cells (  31, 32  ). 
However, loss of TOX does not prevent   Gata3   mRNA up-
regulation in DD thymocytes, suggesting that the Tox      /      
phenotype is not due to loss of GATA-3. Moreover, CD69  + 
CD4  +  8  lo   transitional but not CD4SP thymocytes are present 
in CD4-Cre Gata3  fl  /fl     mice (  32  ). Thus, GATA-3 may play 
a role at a later stage of development than TOX, possibly 
mediating survival of lineage-committed CD4 T cells. In ad-
dition, loss of GATA-3 inhibits development or survival of 
CD4  +   but not DN NKT cells in the thymus (  45  ). This is in 
contrast to TOX defi  ciency that leads to a near-complete loss 
of all CD1d tetramer  +   thymocytes. 
  The helper-defi  cient mutation in the   Zbtb7b   gene also 
prevents CD4 T cell development but, in contrast to the re-
sults reported here, does not inhibit development of CD4  +  8  lo   
thymocytes (  46  ). This is consistent with the relatively late 
  expression of this lineage commitment factor during positive 
selection (  10, 11  ). The failure to detect high-level expression of 
Zbtb7b in Tox      /      thymocytes, then, likely refl  ects the inability 
of the cells to diff  erentiate to the CD4  +  8  lo   developmental stage. 
    Figure 10.         Loss of CD4  +   NKT and T reg mature cells in Tox       /      
mice.   (A) Few    GalCer-CD1d  tetramer +   cells are present in the spleens of 
Tox     /     (  /   ) mice. (B) Tox     /     mice have fewer Foxp3  +   splenic T cells and 
an increased proportion of CD25      CD4     CD8       Foxp3 +   cells. Shown is the 
staining pattern for CD25 and CD4 or CD4 and CD8 among gated Foxp3  +  
splenocytes from +/+ and    /    mice.   254 TOX IS REQUIRED FOR CD4 T CELL DEVELOPMENT | Aliahmad and Kaye
review see reference   39  ), an earlier instructive signal could 
alternatively lead to a parallel pathway of TOX-dependent 
development of this nonconventional T cell subset. 
  MATERIALS AND METHODS 
  Mice.     All mice were bred at The Scripps Research Institute and kept under 
specifi  c pathogen-free conditions.   Tox   genomic fragments were obtained 
from a screen of the RPCI-22 129/SvEvTACBr BAC library (The Centre 
for Applied Genomics, Canada) and cloned into the pFlox vector (  52  ). Gene 
targeting and subsequent transient Cre expression was performed in CMTI-1 
mouse ES cells (derived from 129S6/SvEv strain mice) using standard 
methodology. Heterozygous Tox  +/      mice were bred to generate homozy-
gous Tox      /      and control Tox  +/+   littermates. The generation of TOX-Tg 
and   	  HMG-Tg mice has been described (  21, 22  ).       2  M      /      (  53  ), OT-I 
TCR-Tg (  54  ), and DO11 TCR-Tg (  55  ) mice on either a wild-type or 
Tox      /      background and TAP-1      /      mice (  56  ) were also used. Experiments 
were conducted in accordance with National Institutes of Health guidelines 
for the care and use of animals and with an approved animal protocol from 
The Scripps Research Institute Animal Care and Use Committee. 
  Antibodies, fl   ow cytometry, and Western blotting.     All antibodies 
were purchased from eBioscience or BD Biosciences, except for anti-TOX and 
pan anti-Runx polyclonal antibodies (the latter were provided by M. Satake, 
Tohoku University, Sendai, Japan) that were described previously (  23  ). 
    -GalCer  –  loaded CD1d tetramers were provided by L. Teyton (The Scripps 
Research Institute, La Jolla, CA). Flow cytometry and Western blotting 
were performed as described previously (  23  ). 
  PCR.     Real-time quantitative RT-PCR analysis was performed using the 
standard curve method, where samples were normalized based on   Gapdh   ex-
pression, and analyzed using SDS 2.1 software (Applied Biosystems). Primers 
for real-time RT-PCR were purchased from QIAGEN. Primer sequences 
for   Tox   and   ActB   (    -actin) genomic screens are available upon request. 
  Signaling.     For calcium fl  ux, total thymocytes were labeled at 2   ×   10  7   cells/ml 
with 20     M indo-1 (Invitrogen), followed by surface staining. TCR stimu-
lations were performed by adding purifi  ed functional-grade anti-CD3     mAb 
(clone 2C11; eBioscience) at the indicated concentrations and cross-linking 
bound antibodies with anti  –  hamster IgG at 55   μ  g/ml. The ratio of calcium-
bound indo-1 to free indo-1 was measured as a function of time by fl  ow 
cytometry. For ERK analysis, total thymocytes were prestained with surface 
markers and incubated with 10   μ  g/ml of purifi  ed functional-grade anti-CD3     
mAb for 30 min. TCR cross-linking was performed by adding anti  –  hamster 
IgG at 75   μ  g/ml to prewarmed cells for 2 min. Cells were immediately fi  xed 
in 2% paraformaldehyde for 10 min on ice, washed, and permeabilized in 
100% ice-cold methanol for at least 30 min. Phospho-ERK1/2 was measured 
by intracellular staining (clone E10; Cell Signaling Technology). In some cases, 
500 ng/ml PMA, with or without 50   μ  g/ml of the MEK inhibitor U0126 
(EMD), was used instead of anti-CD3     mAb stimulation. 
  T cell stimulation cultures.     DP thymocyte death curves were calculated 
as the frequency of live cells (negative for staining with annexin V and prop-
idium iodide [PI]) after overnight incubation with 50   μ  g/ml of coimmobi-
lized anti-CD28 mAb and various concentrations of anti-CD3     mAb. In 
some experiments, purifi  ed DP thymocytes were activated with 10   μ  g/ml 
of coimmobilized anti-CD2 and 5   μ  g/ml anti  –  TCR-     antibodies for 14 h 
before analysis of CD4 and CD8 expression by fl  ow cytometry. 
  Splenic CD8 T cells were purifi  ed by negative selection using magnetic 
beads (StemCell Technologies Inc.) and activated at 10  6   cells/ml in 200   μ  l in 
96-well plates with 10   μ  g/ml of immobilized anti-CD3     and 20   μ  g/ml of 
soluble anti-CD28 mAb in the absence or presence of 25 U/ml of recombi-
nant human IL-2. 
  T cells were cultured for 72 h and pulsed with 1     Ci per well of [  3  H]-
TdR for the last 16 h before TdR incorporation was determined. In other 
these TCR to be borderline inducers of negative selection in 
the presence of CD4 (  51  ). Thus, selection for cells that can 
undergo CD4-independent class II MHC  –  specifi  c TCR ac-
tivation during initiation of positive selection in these systems 
appears to eliminate lineage bias. This is in contrast to Tox      /      
mice, where the initiation of positive selection and repertoire 
selection occurs with normal expression of CD4 and where 
normal fi  delity of lineage commitment is largely maintained. 
  The development of Runx3  +   CD8SP thymocytes and 
mature CD8 T cells in Tox      /      mice was puzzling given the 
phenotype of TOX-Tg mice. We have previously demon-
strated that Runx3  +   CD8SP thymocytes develop, although 
do not mature, in TOX-Tg mice, even in the absence of 
positive selection (  23  ). Although these gain-of-function and 
loss-of-function results appear contradictory, we think they 
illustrate the context dependence of TOX function. This was 
evident when TOX-Tg mice were bred to Tox      /      mice. 
CD4 T cell development was restored in Tox      /      mice by 
transgene-encoded TOX, presumably in conjunction with 
appropriate positive selection signals. At the same time, early 
expression of TOX at the DP stage induced an abnormal 
population of CD5  lo/      CD8SP thymocytes, likely formed in 
the absence of positive selection. The competition between 
these eff  ects may also cause the observed reduction in CD4SP 
development in TOX-Tg Tox      /      mice. One intriguing pos-
sibility is that TOX plays a role not only in the DD to 
CD4  +  8  lo   transition, but also in the CD4  +  8  lo   to CD8SP co-
receptor reversal. Ectopic expression of TOX in DP thymo-
cytes could partially mimic this latter activity, potentially 
mediated by Runx3 (  5, 23  ). 
  Additional T cell types formed in the thymus could be 
clearly split into TOX-dependent (NKT and T reg cell) and 
TOX-independent (        T) lineages. The best overall correla-
tion with TOX dependence is positive selection coupled with 
expression of CD4 on a sizeable fraction of the lineage. Most 
T reg cells are CD4  +   cells. However, NKT cells can be DN 
as well as CD4  +   in the thymus (for review see reference   39  ). 
Despite this, both subsets of NKT are derived from DP thymo-
cytes (  38  ). In addition, the appearance of a signifi  cant fraction 
of     GalCer-CD1d tetramer  +   DD thymocytes in newborn 
animals may suggest that both CD4 and DN subsets of devel-
oping NKT pass through a DD stage (  38  ). As with conven-
tional CD4 T cells, therefore, progression from the DD stage 
of NKT cell development may be TOX dependent. 
  The shared role of TOX in the development of conven-
tional CD4 T cells, CD1d-dependent NKT cells, and most 
thymically derived T reg cells may indicate that NKT and 
T reg cells are true CD4 sublineages. Because the initial CD4 
and CD8 lineage split likely occurs at the CD4  +  8  lo   stage of 
positive section, a serial pathway in which development of 
other functional lineages branch off   from the conventional 
CD4 T cell subset is possible. The fact that medullary signals 
may be involved in the induction of Foxp3 would be consis-
tent with such a model (  41  ). In the case of CD1d-dependent 
NKT cells, however, where the TCR-     is invariant and 
there are distinct signaling requirements for development (for JEM VOL. 205, January 21, 2008 
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experiments, total splenocytes were cultured at 10  6   cells/ml in 2 ml with 
50 ng/ml PMA and 500 ng/ml ionomycin for 4 h before cells were surface 
stained for CD40L or internally stained for IFN-    . To generate cytotoxic 
eff  ector cells, purifi  ed splenic H-2  b   CD8 T cells were cultured for 4  –  5 d at 
10  6   cells/ml with 4   ×   10  6   cells/ml irradiated (3,000 rad) red blood cell  –  lysed 
B10.BR splenocytes in the presence of 20 U/ml of recombinant human 
IL-2. Wild-type target spleen cells were labeled with a high (CFSE  hi  ) or low 
(CFSE  lo  ) concentration of CFSE. Activated CD8 T cells were incubated for 
20 h with a 1:1 mixture of CFSE  hi   B10.BR and CFSE  lo   C57BL/6 target cells 
at the indicated E/T ratios. Loss of CFSE  hi   or CFSE  lo   cells among the viable 
cell population was determined by fl  ow cytometry. The percentage of spe-
cifi  c lysis was determined by the following formulas: ratio = (percentage of 
CFSE  hi  /percentage of CFSE  lo  ); percentage of specifi  c lysis = [1     (ratio in 
the presence of eff  ector cells/ratio in the absence of eff  ector cells)   ×   100]. 
  BM chimeric mice.     Recipient CD90.1 mice were lethally irradiated (990 
rads) to deplete hematopoietic cells. A 1:1 mixture of donor wild-type 
(CD90.2  +  CD45.1  +  ) and Tox      /      (CD90.2  +   CD45.2  +  ) lin        BM cells was in-
jected intravenously, and chimeras were analyzed 5  –  8 wk later. More than 
98% of thymocytes were of donor origin in these mice. In other experiments, 
lethally irradiated     2M      /      or TAP-1      /      hosts were reconstituted with 
wild-type or Tox      /      BM. 
  Microscopy.     5-    m frozen sections from the thymuses of BM chimeric 
mice were immunostained and analyzed for the expression of CD45.1 and 
CD45.2 as well as binding of   Ulex europaeus   agglutinin (Vector Laboratories) 
and visualized by a MRC1024 laser scanning confocal microscope (BioRad 
Laboratories) at a magnifi  cation of 20. 
  Statistics.     The probability (  P  ) associated with a Student  ’  s   t   test using a two-
tailed distribution of equal variance is shown in some fi  gures. 
  Online supplemental material.     Fig. S1 shows that loss of TOX does not 
aff  ect B cell development. Fig. S2 shows initiation of positive selection in 
Tox      /      mice as analyzed by CD69 up-regulation. Fig. S3 shows class I MHC 
dependence of generation of splenic CD8 T cells in Tox      /      mice. Figs. S1 –  S3 
are available at http://www.jem.org/cgi/content/full/jem.20071944/DC1. 
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